These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38550125)

  • 1. Retracted: A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein.
    International BR
    Biomed Res Int; 2024; 2024():9784929. PubMed ID: 38550125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein.
    Srivastava VK; Kaushik S; Bhargava G; Jain A; Saxena J; Jyoti A
    Biomed Res Int; 2021; 2021():7251119. PubMed ID: 34651048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Comparative Analysis of the Functional, Structural, and Evolutionary Properties of SARS-CoV-2 Variant Spike Proteins.
    Math RK; Mudennavar N; Javaregowda PK; Savanur A
    JMIR Bioinform Biotechnol; 2022; 3(1):e37391. PubMed ID: 35669291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a multi-epitope-based peptide vaccine against the
    Roohparvar Basmenj E; Omidvar B; Kiumarsy A; Izadkhah H; Ghiabi S
    J Biomol Struct Dyn; 2023 Aug; ():1-12. PubMed ID: 37539837
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
    Alsoussi WB; Malladi SK; Zhou JQ; Liu Z; Ying B; Kim W; Schmitz AJ; Lei T; Horvath SC; Sturtz AJ; McIntire KM; Evavold B; Han F; Scheaffer SM; Fox IF; Mirza SF; Parra-Rodriguez L; Nachbagauer R; Nestorova B; Chalkias S; Farnsworth CW; Klebert MK; Pusic I; Strnad BS; Middleton WD; Teefey SA; Whelan SPJ; Diamond MS; Paris R; O'Halloran JA; Presti RM; Turner JS; Ellebedy AH
    Nature; 2023 May; 617(7961):592-598. PubMed ID: 37011668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses.
    Levy Y; Alcalay R; Zvi A; Makdasi E; Peretz E; Noy-Porat T; Chitlaru T; Mandelboim M; Mazor O; Rosenfeld R
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
    Alsoussi WB; Malladi SK; Zhou JQ; Liu Z; Ying B; Kim W; Schmitz AJ; Lei T; Horvath SC; Sturtz AJ; McIntire KM; Evavold B; Han F; Scheaffer SM; Fox IF; Parra-Rodriguez L; Nachbagauer R; Nestorova B; Chalkias S; Farnsworth CW; Klebert MK; Pusic I; Strnad BS; Middleton WD; Teefey SA; Whelan SPJ; Diamond MS; Paris R; O'Halloran JA; Presti RM; Turner JS; Ellebedy AH
    bioRxiv; 2022 Sep; ():. PubMed ID: 36172127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2.
    Zaib S; Akram F; Liaqat ST; Altaf MZ; Khan I; Dera AA; Uddin J; Khan A; Al-Harrasi A
    Sci Rep; 2022 Nov; 12(1):19087. PubMed ID: 36352060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics.
    Pritam M; Dutta S; Medicherla KM; Kumar R; Singh SP
    J Biomol Struct Dyn; 2023 Jul; ():1-19. PubMed ID: 37498146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens.
    Counoupas C; Pino P; Stella AO; Ashley C; Lukeman H; Bhattacharyya ND; Tada T; Anchisi S; Metayer C; Martinis J; Aggarwal A; Dcosta BM; Britton WJ; Kint J; Wurm MJ; Landau NR; Steain M; Turville SG; Wurm FM; David SA; Triccas JA
    Microbiol Spectr; 2022 Feb; 10(1):e0169521. PubMed ID: 35171046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates.
    Ashik AI; Hasan M; Tasnim AT; Chowdhury MB; Hossain T; Ahmed S
    Heliyon; 2020 Sep; 6(9):e04865. PubMed ID: 32923731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2.
    Dawood RM; El-Meguid MA; Salum GM; El-Wakeel K; Shemis M; El Awady MK
    J Infect Public Health; 2021 Feb; 14(2):169-178. PubMed ID: 33486372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction and analysis of B cell and T cell epitopes in the spike protein of SARS-CoV-2 by bioinformatics].
    Tao J; Li S; Yang J; Zhang T; Lyu Y; Zhao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jan; 39(1):49-56. PubMed ID: 36631015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Beta Strain-Based Spike Glycoprotein Vaccine Candidate Induces Broad Neutralization and Protection against SARS-CoV-2 Variants of Concern.
    Cao L; Guo J; Li H; Ren H; Xiao K; Zhang Y; Zhu S; Song Y; Zhao W; Wu D; Chen Z; Zhang Y; Xia B; Ji T; Yan D; Wang D; Yang Q; Zhou Y; Li X; Hou Z; Xu W
    Microbiol Spectr; 2023 Feb; 11(2):e0268722. PubMed ID: 36847495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AlphaFold2-Enabled Atomistic Modeling of Structure, Conformational Ensembles, and Binding Energetics of the SARS-CoV-2 Omicron BA.2.86 Spike Protein with ACE2 Host Receptor and Antibodies: Compensatory Functional Effects of Binding Hotspots in Modulating Mechanisms of Receptor Binding and Immune Escape.
    Raisinghani N; Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
    J Chem Inf Model; 2024 Mar; 64(5):1657-1681. PubMed ID: 38373700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Development of SARS-CoV-2 Spike Interactors.
    Squeglia F; Romano M; Esposito L; Barra G; Campiglia P; Sala M; Scala MC; Ruggiero A; Berisio R
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-variant proof predictive vaccine design based on SARS-CoV-2 spike protein using immunoinformatics approach.
    Sahu LK; Singh K
    Beni Suef Univ J Basic Appl Sci; 2023; 12(1):5. PubMed ID: 36644779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast Prediction of Binding Affinities of the SARS-CoV-2 Spike Protein Mutant N501Y (UK Variant) with ACE2 and Miniprotein Drug Candidates.
    Williams AH; Zhan CG
    J Phys Chem B; 2021 May; 125(17):4330-4336. PubMed ID: 33881861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.